March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.
By Dan Cossins | March 1, 2013
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
March 14, 2013
Any drug they will develop to block the enzyme will have side effects. So, a better approach is to quit smoking. Mochael Lerman, M.D., Ph.D.
By Kerry Grens
Assistant Professor, Department of Cell & Tissue Biology, University of California, San Francisco. Age: 38
By Jef Akst
Researchers and regulators reflect on the progress that has been made in preventing tobacco-related disease in the 50 years since the publication of the first U.S. Surgeon General’s report.
Genomic structures called i-motifs signal DNA activation, while hairpin loops signal gene suppression.
View the September 2014 contents.
© 1986-2014 The Scientist